As of April 2024 AcelRx Pharmaceuticals has a market cap of $14.57 Million. This makes AcelRx Pharmaceuticals the world's 8042th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $14.57 M | 17.01% |
2023 | $12.45 M | -25.99% |
2022 | $16.83 M | -74.81% |
2021 | $66.84 M | -40.42% |
2020 | $0.11 B | -33.18% |
2019 | $0.16 B | -7.71% |
2018 | $0.18 B | 78.48% |
2017 | $0.10 B | -13.52% |
2016 | $0.11 B | -32.38% |
2015 | $0.17 B | -40.75% |
2014 | $0.29 B | -39.58% |
2013 | $0.48 B | 208.45% |
2012 | $0.15 B | 320.48% |
2011 | $37.54 M |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Recro Pharma
REPH | $0.12 B | 745.28% | ๐บ๐ธ USA |
Cara Therapeutics
CARA | $36.12 M | 147.81% | ๐บ๐ธ USA |